Login

Join for Free!
61311 members
table of contents table of contents

This study supports the use of non-HDL cholesterol as the more practical …


');

Biology Articles » Biochemistry » Lipid Biochemistry » The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis » Tables

Tables
- The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis

Table 1

Clinical and Metabolic characteristics of subjects

Variable
Non-Diabetics
Diabetics
P-Value
N
462
271

Age (years)
45.03 ± 11.52
52.73 ± 11.45
0.000
Systolic BP (mmHg)
120.57 ± 18.23
130.17 ± 19.74
0.000
Diastolic BP (mmHg)
78.15 ± 11.65
82.27 ± 10.71
0.000
BMI (kg/m2)
28.91 ± 6.07
30.15 ± 6.62
0.011
LDL (mmol/L)
3.63 ± 1.31
3.47 ± 1.55
0.17
HDL (mmol/L)
0.91 ± 0.45
0.80 ± 0.32
0.000
Non-HDL (mmol/L)
4.36 ± 1.47
4.67 ± 1.54
0.009
Total Cholesterol (mmol/Ll)
5.26 ± 1.39
5.52 ± 1.74
0.04
Triglycerides (mmol/L)
1.74 ± 1.06
2.63 ± 1.37
0.000

* Data are presented as mean ± SD; p-value significant at

Al-Daghri et al. Lipids in Health and Disease 2007 6:9   doi:10.1186/1476-511X-6-9

Table 2

Relative risk of probable coronary heart disease for various cut-off values of lipids


Non-Diabetic
Diabetic
N
465
271
Probable CHD
99
114
LDL cholesterol (mmol/L)


0.87 (0.70–1.09)
0.95 (0.86–1.05)
2.59–3.34
0.99 (0.76–1.30)
1.03 (0.91–1.17)
≥ 3.35
1.05 (0.92–1.19)
1.13 (0.91–1.39)
Non-HDL- cholesterol (mmol/L)


0.94 (0.85–1.04)
0.95 (0.74–1.22)
3.35–4.13
0.86 (0.67–1.09)
1.06 (0.93–1.21)
≥ 4.14
1.01 (0.92–1.11)
1.15 (0.93–1.42)
Total Cholesterol (mmol/L)


1.02 (0.93–1.12
0.81 (0.65–1.00)
5.17–6.19
0.93 (0.84–1.03)
1.11 (0.86–1.44)
≥ 6.20
1.09 (0.95–1.24)
1.18 (0.91–1.53)
HDL Cholesterol (mg/dl)


≥ 1.55
0.85 (0.76–0.96)
1.76 (0.56–5.47)
1.03–1.54
1.10 (0.96–1.25)
1.37 (0.98–1.91)
0.99 (0.89–1.10)
0.70 (0.51–0.97)
Triglycerides (mg/dl)


0.79 (0.70–0.89)
0.96 (0.75–1.23)
1.69–2.25
0.98 (0.86–1.11)
1.20 (0.86–1.67)
≥ 2.26
1.05 (0.93–1.19)
0.94 (0.75–1.46)

*Data presented as Relative risk (95% Confidence interval)

Al-Daghri et al. Lipids in Health and Disease 2007 6:9   doi:10.1186/1476-511X-6-9

Table 3

Logistic regression analysis using probable CHD as a dependent variable and the various lipids as independent variables

Non-Diabetics
Predictor
β
SE
Odds-Ratio
95% Confidence Interval
P-Value
Non-HDL
1.06
0.49
2.89
1.10–7.58
0.03
HDL
-0.19
0.27
0.83
0.49–1.40
0.48
LDL
-0.65
0.48
0.52
0.21–1.32
0.17
Triglycerides
0.07
0.25
1.07
0.65–1.76
0.79
Total Cholesterol
-0.36
0.29
0.69
0.39–1.23
0.21

β – Beta; SE – standard error

Al-Daghri et al. Lipids in Health and Disease 2007 6:9   doi:10.1186/1476-511X-6-9

Table 4

Logistic regression analysis using probable CHD as a dependent variable and the various lipids as independent variables

Diabetics
Predictor
β
SE
Odds-Ratio
95% Confidence Interval
P-Value
Non-HDL
-0.26
0.51
0.77
0.28–2.01
0.61
HDL
-0.66
0.33
0.52
0.27–0.99
0.05
LDL
0.16
0.47
1.18
0.47–2.93
0.73
Triglycerides
0.09
0.31
1.09
0.59–2.01
0.78
Total Cholesterol
0.31
0.35
1.36
0.68–2.71
0.39

β – Beta; SE – standard error

Al-Daghri et al. Lipids in Health and Disease 2007 6:9   doi:10.1186/1476-511X-6-9


rating: 5.00 from 1 votes | updated on: 18 Nov 2007 | views: 4136 |

Rate article:







excellent!bad…